137 related articles for article (PubMed ID: 17935781)
1. Mutation analysis of AML1 gene in pediatric primary myelodysplastic syndrome and juvenile myelomonocytic leukemia.
Masunaga A; Mitsuya T; Kadofuku T; Iwamoto S; Miyazaki A; Manabe A; Zaike Y; Tsuchida M; Nakahata T
Leuk Res; 2008 Jun; 32(6):995-7. PubMed ID: 17935781
[No Abstract] [Full Text] [Related]
2. AML1/RUNX1 gene point mutations in childhood myeloid malignancies.
Migas A; Savva N; Mishkova O; Aleinikova OV
Pediatr Blood Cancer; 2011 Oct; 57(4):583-7. PubMed ID: 21294243
[TBL] [Abstract][Full Text] [Related]
3. AML1 mutation and FLT3-internal tandem duplication in leukemia transformed from myelodysplastic syndrome.
Shimada A; Taketani T; Kikuchi A; Hanada R; Arakawa H; Kimura H; Chen Y; Hayashi Y
J Pediatr Hematol Oncol; 2007 Sep; 29(9):666-7. PubMed ID: 17805050
[No Abstract] [Full Text] [Related]
4. RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome.
Chen CY; Lin LI; Tang JL; Ko BS; Tsay W; Chou WC; Yao M; Wu SJ; Tseng MH; Tien HF
Br J Haematol; 2007 Nov; 139(3):405-14. PubMed ID: 17910630
[TBL] [Abstract][Full Text] [Related]
5. CBL mutations in juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome.
Shiba N; Kato M; Park MJ; Sanada M; Ito E; Fukushima K; Sako M; Arakawa H; Ogawa S; Hayashi Y
Leukemia; 2010 May; 24(5):1090-2. PubMed ID: 20357823
[No Abstract] [Full Text] [Related]
6. DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia.
Shiba N; Taki T; Park MJ; Shimada A; Sotomatsu M; Adachi S; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Arakawa H; Hayashi Y
Br J Haematol; 2012 Feb; 156(3):413-4. PubMed ID: 21981547
[No Abstract] [Full Text] [Related]
7. SETBP1 mutations in juvenile myelomonocytic leukaemia and myelodysplastic syndrome but not in paediatric acute myeloid leukaemia.
Shiba N; Ohki K; Park MJ; Sotomatsu M; Kudo K; Ito E; Sako M; Arakawa H; Hayashi Y
Br J Haematol; 2014 Jan; 164(1):156-9. PubMed ID: 24117422
[No Abstract] [Full Text] [Related]
8. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options.
Niemeyer CM; Kratz CP
Br J Haematol; 2008 Mar; 140(6):610-24. PubMed ID: 18302710
[TBL] [Abstract][Full Text] [Related]
9. Long-term haematological improvement after non-intensive or no chemotherapy in juvenile myelomonocytic leukaemia and poor correlation with adult myelodysplasia spliceosome-related mutations.
Matsuda K; Yoshida N; Miura S; Nakazawa Y; Sakashita K; Hyakuna N; Saito M; Kato F; Ogawa A; Watanabe A; Sotomatsu M; Kobayashi C; Ito T; Ishida F; Manabe A; Kojima S; Koike K
Br J Haematol; 2012 Jun; 157(5):647-50. PubMed ID: 22348520
[No Abstract] [Full Text] [Related]
10. Mutational analysis of RNA splicing machinery components in 206 children with myeloid malignancies.
Sakaguchi H; Makishima H; Muramatsu H; Visconte V; Jerez A; Jankowska AM; Tiu RV; Maciejewski JP; Kojima S
Leuk Res; 2012 Dec; 36(12):e215-7. PubMed ID: 22748922
[No Abstract] [Full Text] [Related]
11. [Distinct genetic pathway in the molecular pathogenesis of MDS/AML with AML1/RUNX1 point mutations].
Harada H
Rinsho Ketsueki; 2007 Jul; 48(7):541-6. PubMed ID: 17695302
[No Abstract] [Full Text] [Related]
12. Fanconi Anemia patient with AML1 gene amplification and monosomy 7 in pre-transplant myelodysplasia (MDS) relapsing 7 years after successful allo-SCT.
Ayas M; Walter C
Bone Marrow Transplant; 2008 Oct; 42(8):555-7. PubMed ID: 18622412
[No Abstract] [Full Text] [Related]
13. Mutation analysis of SIPA1 in patients with juvenile myelomonocytic leukemia.
Yoshida N; Yagasaki H; Takahashi Y; Kudo K; Manabe A; Kojima S
Br J Haematol; 2008 Sep; 142(5):850-1. PubMed ID: 18492118
[No Abstract] [Full Text] [Related]
14. Mutation analysis of the BRAF oncogene in juvenile myelomonocytic leukemia.
de Vries AC; Stam RW; Kratz CP; Zenker M; Niemeyer CM; van den Heuvel-Eibrink MM;
Haematologica; 2007 Nov; 92(11):1574-5. PubMed ID: 18024410
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of TP53 in childhood myelodysplastic syndrome and juvenile myelomonocytic leukemia.
Saito S; Matsuda K; Taira C; Sano K; Tanaka-Yanagisawa M; Yanagisawa R; Nakazawa Y; Sakashita K; Shiohara M; Koike K
Leuk Res; 2011 Dec; 35(12):1578-84. PubMed ID: 21784522
[TBL] [Abstract][Full Text] [Related]
16. Juvenile myelomonocytic leukemia with less aggressive clinical course and KRAS mutation.
Imamura M; Imai C; Takachi T; Nemoto T; Tanaka A; Uchiyama M
Pediatr Blood Cancer; 2008 Oct; 51(4):569. PubMed ID: 18561174
[No Abstract] [Full Text] [Related]
17. Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.
Pérez B; Kosmider O; Cassinat B; Renneville A; Lachenaud J; Kaltenbach S; Bertrand Y; Baruchel A; Chomienne C; Fontenay M; Preudhomme C; Cavé H
Br J Haematol; 2010 Dec; 151(5):460-8. PubMed ID: 20955399
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
19. Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA.
Chinen Y; Taki T; Nishida K; Shimizu D; Okuda T; Yoshida N; Kobayashi C; Koike K; Tsuchida M; Hayashi Y; Taniwaki M
Oncogene; 2008 Apr; 27(15):2249-56. PubMed ID: 17968322
[TBL] [Abstract][Full Text] [Related]
20. Constitutional RUNX1 deletion presenting as non-syndromic thrombocytopenia with myelodysplasia: 21q22 ITSN1 as a candidate gene in mental retardation.
van der Crabben S; van Binsbergen E; Ausems M; Poot M; Bierings M; Buijs A
Leuk Res; 2010 Jan; 34(1):e8-12. PubMed ID: 19679353
[No Abstract] [Full Text] [Related]
[Next] [New Search]
